About 198 results

ALLMedicine™ Parathyroid Hormone-related Peptide Center

Research & Reviews  76 results

Parathyroid Hormone-Related Peptide

May 5th, 2022 - No detectable (or minimal) parathyroid hormone–related protein (PTHrP) is normal. Over the last 20-25 years, our understanding of PTHrP has magnified along with our ability to discern the role PTH in multiple physiologic and pathologic conditions....

Parathyroid Hormone-Related Peptide

May 5th, 2022 - Reference Range No detectable (or minimal) parathyroid hormone–related protein (PTHrP) is normal. Next: Interpretation Over the last 20-25 years, our understanding of PTHrP has magnified along with our ability to discern the role PTH in multiple p...

Whole-body and adipose tissue metabolic phenotype in cancer patients.
Journal of Cachexia, Sarcopenia and Muscle; Anderson LJ, Lee J et. al.

Jan 29th, 2022 - Altered adipose tissue (AT) metabolism in cancer-associated weight loss via inflammation, lipolysis, and white adipose tissue (WAT) browning is primarily implicated from rodent models; their contribution to AT wasting in cancer patients is unclear...

Missed diagnosis of lymphoma presenting with humoral hypercalcemia of malignancy due to...
BMJ Case Reports; Altshuler E, Aryan M et. al.

Jan 1st, 2022 - Malignancy is the most common cause of hypercalcemia among hospitalised patients and is frequently caused by elevations in parathyroid hormone-related peptide (PTHrP). The most common PTHrP-producing cancers are carcinomas of the head, neck and lu...

Involvement of parathyroid hormone-related peptide in the aggressive phenotype of color...
World Journal of Gastroenterology; Novoa Díaz MB, Carriere PM et. al.

Dec 11th, 2021 - Colorectal cancer (CRC) remains one of the leading causes of mortality from malignant diseases worldwide. In general terms, CRC presents high heterogeneity due to the influence of different genetic and environmental factors; also, the neoplastic c...

see more →

Clinicaltrials.gov  1 results

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)

Apr 24th, 2014 - Bone metastases are frequently one of the first signs of disseminated disease in cancer patients. Skeletal complications due to metastatic disease include (severe) bone pain, spinal cord compromise, pathological fractures, and hypercalcemia. Zoled...

see more →

News  2 results

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis

Abstract and Introduction Abstract Context: Abaloparatide is a US Food and Drug Administration-approved parathyroid hormone-related peptide analog for treatment of osteoporosis in postmenopausal women at high risk of fracture. Objectives: We asses...

Mechanisms of Cancer Cell Metastasis to the Bone

Types of Bone Metastatic Tumors Leo Tolstoy began his 1873 work; 'Anna Karenina', with the line, "Happy families are all alike; every unhappy family is unhappy in its own way".[52] While the subject of Tolstoy's work is vastly different from that ...

see more →